Whether monoallelic MUTYH mutations increase female breast cancer risk remains controversial. This study aimed to determine if monoallelic MUTYH mutations are associated with increased breast cancer risk in women undergoing multigene panel testing (MGPT). The prevalence of monoallelic MUTYH mutations was compared between Non-Hispanic white female breast cancer cases (n = 30,456) and cancer-free controls (n = 12,289), all of whom underwent MGPT that included MUTYH. We tested breast cancer associations with MUTYH alleles using Fisher’s exact test, followed by multivariate logistic regression adjusted for age at testing and MGPT type ordered. Frequencies of the two most common MUTYH founder mutations, p.G396D and p.Y179C, were compared independently between the breast cancer cases and MGPT controls, as well as the healthy UK10K control population (n = 2640). Comparing cases to MGPT controls, no association was observed between female breast cancer and any monoallelic MUTYH carrier status (OR 0.86–1.36, p = 0.21–0.96). Similarly, comparisons to UK10K controls revealed no significant increase in breast cancer risk associated with p.G396D (OR 1.20, p = 0.44) or p.Y179C (OR 1.71, p = 0.24). This study did not find a significant increase in breast cancer risk associated with monoallelic MUTYH mutations.
Breast cancer MUTYH carrier Monoallelic MUTYHMultigene panel testing Colorectal cancer
This is a preview of subscription content, log in to check access.
Compliance with ethical standards
Conflict of interest
C.E. was a full-time salaried employee of Ambry Genetics during the time she worked on this study and is currently a full-time salaried employee of Guardant Health. All other authors are currently full-time salaried employees of Ambry Genetics.
Cleary SP, Cotterchio M, Jenkins MA et al (2009) Germline MutY human homologue mutations and colorectal cancer: a multisite case-control study. Gastroenterology 136:1251–1260CrossRefGoogle Scholar
Lubbe SJ, Di Bernardo MC, Chandler IP et al (2009) Clinical implications of the colorectal cancer risk associated with MUTYH mutation. J Clin Oncol 27:3975–3980CrossRefGoogle Scholar
Theodoratou E, Campbell H, Tenesa A et al (2010) A large-scale meta-analysis to refine colorectal cancer risk estimates associated with MUTYH variants. Br J Cancer 103:1875–1884CrossRefGoogle Scholar
Win AK, Dowty JG, Cleary SP et al (2014) Risk of colorectal cancer for carriers of mutations in MUTYH, with and without a family history of cancer. Gastroenterology 146:1208–1211.e1–5CrossRefGoogle Scholar
Vogt S, Jones N, Christian D et al (2009) Expanded extracolonic tumor spectrum in MUTYH-associated polyposis. Gastroenterology 137:1976–85.e10CrossRefGoogle Scholar
Kanter-Smoler G, Björk J, Fritzell K et al (2006) Novel findings in Swedish patients with MYH-associated polyposis: mutation detection and clinical characterization. Clin Gastroenterol Hepatol 4:499–506CrossRefGoogle Scholar
Sieber OM, Lipton L, Crabtree M et al (2003) Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791–799CrossRefGoogle Scholar
Win AK, Hopper JL, Jenkins MA (2011) Association between monoallelic MUTYH mutation and colorectal cancer risk: a meta-regression analysis. Fam Cancer 10:1–9CrossRefGoogle Scholar
Rennert G, Lejbkowicz F, Cohen I et al (2012) MutYH mutation carriers have increased breast cancer risk. Cancer 118:1989–1993CrossRefGoogle Scholar
Zhu M, Chen X, Zhang H et al (2011) AluYb8 insertion in the MUTYH gene and risk of early-onset breast and gastric cancers in the Chinese population. Asian Pac J Cancer Prev 12:1451–1455Google Scholar
Beiner M, Zhang W, Zhang S et al (2009) Mutations of the MYH gene do not substantially contribute to the risk of breast cancer. Breast Cancer Res Treat 114:575–578CrossRefGoogle Scholar
Out AA, Wasielewski M, Huijts PE et al (2012) MUTYH gene variants and breast cancer in a Dutch case-control study. Breast Cancer Res Treat 134:219–227CrossRefGoogle Scholar
Win AK, Reece JC, Dowty JG et al (2016) Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH. Int J Cancer 139:1557–1563CrossRefGoogle Scholar
UK10K Consortium, Walter K, Min JL et al (2015) The UK10K project identifies rare variants in health and disease. Nature 526:82–90CrossRefGoogle Scholar
LaDuca H, Stuenkel AJ, Dolinsky JS et al (2014) Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients. Genet Med 16(11):830–837CrossRefGoogle Scholar
Richards S, Aziz N, Bale S et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17(5):405–424CrossRefGoogle Scholar
Win AK, Cleary SP, Dowty JG et al (2011) Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer. Int J Cancer 129:2256–2262CrossRefGoogle Scholar
Horton C, LaDuca H, McFarland R et al (2017) In laboratory clinical data we trust? Accuracy and completeness of test requisition form data in a cohort of ovarian and uterine cancer patients referred for clinical genetic testing. In: 48th annual conference of the society of gynecologic oncology; March 12–15; National Harbor, MDGoogle Scholar